Why choose us
Not just another CRO, custom made for your needs
- We are acknowledged as one of the few companies in Eastern Europe and Europe that carry Early phase clinical trials.
- We are active contributors to essential life-changing products that benefit patients worldwide.
- For us, safety comes always first. We have great experience in the selection and specialized care for the subjects enrolled in our studies design.
- We have seamlessly managed over +1500 registered clinical studies on the behalf of our partner companies, bringing added value through high clinical expertise and cost efficiency.
- Regulatory excellence: recently inspected by US FDA (2023) and EMA (2024) with positive outcomes. We have validated international expertise in complex clinical studies. The clinical studies conducted in Romania and Moldova have been inspected by numerous European Authorities including those from France, Germany, Austria, The Netherlands, Island and others.
- Our team has 50+ members, more than half are University graduated scientists such as medical doctors, pharmacists, biologists and other support certified members.
- Our facility provides long term confinement, with the possibility of simultaneous dosing of a large group of subjects
- We bring our deep scientific expertise to each and every study. We are performing a wide range of studies: Phase I studies including First In Human studies, BA/BE studies ( bioequivalence / bioavailability studies), drug-drug interaction, pharmacokinetic profiles, adhesion performance, pain assessment studies and other complex studies.
STATE-OF-THE ART TECHNOLOGY
Enabling excellent outcomes through technology and personalization
Our in-house laboratory
Our dedicated experts support you along your product development by tailored design study approach.
That is why, the 3S Pharma state-of-the-art analytical laboratory ensures excellency through 4 robotic systems for automatic sample preparation and other high-end technologies (eg. Infolab – dedicated software for error free samples tracking).
Our bioanalytical laboratory is equipped to support your project at any stage, from discovery through preclinical to clinical phases, ensuring seamless progression with tailored expertise and cutting-edge technology for every step of your product development journey:
- Discovery
- Preclinical
- Clinical
Also, our in-house bioanalytical laboratory has the capability of analyzing over 100.000 samples, yearly. This allows us to leverage established technologies, proprietary approaches, and develop and validate biomarker assays to generate robust biomarker data in samples.
Our bioanalytical laboratory is specialized in HPLC-MS/MS (high sensitivity instruments for small and large molecules) and LBA (ligand binding assay).
Other technologies used in clinical studies at 3S Pharma
The technologies we use in the clinical studies we perform are not limited to the laboratory assets, we use innovative technologies also in the clinical stage we perform, such as:
- thermal photography
- chroma meters
- ultrasonography
- superficial veins detectors
- oxygen monitoring
- electric pill grinder for tablets
AWARDS
Euro Health Leaders
With a legacy of innovation and excellence, 3S Pharma is a trusted partner for clinical research needs worldwide. Its focus on advancing global health through cutting-edge clinical research positions it as a pioneering force in the pursuit of safer and more effective therapies.
3S Pharma Awarded By Life Sciences
This award is in recognition of 3S Pharma’s stellar reputation and trust among customers and industry peers, evident in the numerous nominations we received from our subscribers. 3S Pharma emerged as the CRO of the Year in Europe 2025 after an exhaustive evaluation by an expert panel of C-level executives, industry thought leaders, and our editorial board.
